The Evolving Role of Tau in Neurodegeneration

A comprehensive look at biomarkers and clinical applications

 

Whitepaper

 

Tau is emerging as a critical biomarker in Alzheimer’s disease, advancing early diagnosis, prognosis, and treatment monitoring.

This whitepaper explores:

  • Key Tau biomarkers (p-Tau 181, p-Tau 217, p-Tau 231)
  • Cutting-edge detection methods in blood, CSF, and brain imaging
  • The impact of Tau biomarkers on Alzheimer’s research and clinical applications

Download now to explore the latest advancements